» Articles » PMID: 36774227

Could Alzheimer's Disease Be a Maladaptation of an Evolutionary Survival Pathway Mediated by Intracerebral Fructose and Uric Acid Metabolism?

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2023 Feb 11
PMID 36774227
Authors
Affiliations
Soon will be listed here.
Abstract

An important aspect of survival is to assure enough food, water, and oxygen. Here, we describe a recently discovered response that favors survival in times of scarcity, and it is initiated by either ingestion or production of fructose. Unlike glucose, which is a source for immediate energy needs, fructose metabolism results in an orchestrated response to encourage food and water intake, reduce resting metabolism, stimulate fat and glycogen accumulation, and induce insulin resistance as a means to reduce metabolism and preserve glucose supply for the brain. How this survival mechanism affects brain metabolism, which in a resting human amounts to 20% of the overall energy demand, is only beginning to be understood. Here, we review and extend a previous hypothesis that this survival mechanism has a major role in the development of Alzheimer's disease and may account for many of the early features, including cerebral glucose hypometabolism, mitochondrial dysfunction, and neuroinflammation. We propose that the pathway can be engaged in multiple ways, including diets high in sugar, high glycemic carbohydrates, and salt. In summary, we propose that Alzheimer's disease may be the consequence of a maladaptation to an evolutionary-based survival pathway and what had served to enhance survival acutely becomes injurious when engaged for extensive periods. Although more studies are needed on the role of fructose metabolism and its metabolite, uric acid, in Alzheimer's disease, we suggest that both dietary and pharmacologic trials to reduce fructose exposure or block fructose metabolism should be performed to determine whether there is potential benefit in the prevention, management, or treatment of this disease.

Citing Articles

Do microglia metabolize fructose in Alzheimer's disease?.

Sturno A, Hassell Jr J, Lanaspa M, Bruce K J Neuroinflammation. 2025; 22(1):85.

PMID: 40089786 DOI: 10.1186/s12974-025-03401-x.


Serum Uric Acid and Bone Health in Middle-Aged and Elderly Hypertensive Patients: A Potential U-Shaped Association and Implications for Future Fracture Risk.

Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H Metabolites. 2025; 15(1).

PMID: 39852358 PMC: 11766991. DOI: 10.3390/metabo15010015.


Amino Acid Compound 2 (AAC2) Treatment Counteracts Insulin-Induced Synaptic Gene Expression and Seizure-Related Mortality in a Mouse Model of Alzheimer's Disease.

Deng Z, Lee A, Lin T, Taneja S, Kowdley D, Leung J Int J Mol Sci. 2024; 25(21).

PMID: 39519239 PMC: 11546384. DOI: 10.3390/ijms252111689.


Obesity, Metabolic Syndrome, and Sugar-Sweetened Beverages (SSBs) in America: A Novel Bioethical Argument for a Radical Public Health Proposal.

Gentzel M J Bioeth Inq. 2024; .

PMID: 39259474 DOI: 10.1007/s11673-024-10369-5.


Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta-analysis based on latest evidence.

Wang L, Tan Z, Wang F, Wu W, Wu J Brain Behav. 2023; 13(10):e3207.

PMID: 37667521 PMC: 10570495. DOI: 10.1002/brb3.3207.


References
1.
Lanaspa M, Ishimoto T, Li N, Cicerchi C, Orlicky D, Ruzycki P . Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun. 2013; 4:2434. PMC: 3833672. DOI: 10.1038/ncomms3434. View

2.
Youn J, Kaslow H, Bergman R . Fructose effect to suppress hepatic glycogen degradation. J Biol Chem. 1987; 262(24):11470-7. View

3.
Andres-Hernando A, Cicerchi C, Kuwabara M, Orlicky D, Sanchez-Lozada L, Nakagawa T . Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation. Nat Metab. 2021; 3(9):1189-1201. PMC: 9987717. DOI: 10.1038/s42255-021-00454-z. View

4.
Jang C, Hui S, Lu W, Cowan A, Morscher R, Lee G . The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. Cell Metab. 2018; 27(2):351-361.e3. PMC: 6032988. DOI: 10.1016/j.cmet.2017.12.016. View

5.
Pliquett R, Fuhrer D, Falk S, Zysset S, von Cramon D, Stumvoll M . The effects of insulin on the central nervous system--focus on appetite regulation. Horm Metab Res. 2006; 38(7):442-6. DOI: 10.1055/s-2006-947840. View